Regenerative Medical Technology Group Inc.: cash_and_equivalents
| Value | {"amount": 11379, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | Regenerative Medical Technology Group Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d02b2460-6ce8-40cc-848d-9ead7782f8ca
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-026825Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001760026/cash-and-equivalents/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d02b2460-6ce8-40cc-848d-9ead7782f8ca
History
- supersedes {"amount": 11297, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001213900-21-000746)